Cognition Therapeutics, Inc.
CGTX
$2.86
-$0.325-10.22%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | 4.36% | 7.33% | 3.67% | -47.24% | -48.98% |
| Total Depreciation and Amortization | -8.96% | -22.41% | 7.58% | 7.69% | 9.84% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -45.86% | -57.10% | -50.14% | -16.34% | 11.90% |
| Change in Net Operating Assets | 352.35% | -519.88% | -173.97% | 46.01% | -203.57% |
| Cash from Operations | 6.24% | -36.35% | -53.63% | -64.65% | -62.26% |
| Capital Expenditure | -- | -- | 96.67% | 100.00% | 83.33% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | 96.67% | 100.00% | 83.33% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | 33.70% | 33.71% | -8.94% | 13.95% | 13.81% |
| Issuance of Common Stock | -37.09% | -88.11% | 392.93% | 142.45% | -39.52% |
| Repurchase of Common Stock | 77.27% | 56.60% | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 644.93% | -89.19% | 366.63% | 11,066.67% | -106.59% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 20.64% | -280.69% | 198.39% | -54.51% | -278.89% |